In the present study, we showed that the oncolytic VACV GLV-1h68 and its derivative GLV-1h108 [28], which encodes for a single chain antibody (scAb) against VEGF revealed significant tumor growth control and prevented formation of ME in a subcutaneous advanced-stage lung adenocarcinoma model. The gene discussed is VEGFA; the disease is neoplasm.